Eurosports Global Limited Receives SGX Approval-In-Principle for S\$1.99 Million Share Subscription
Key Highlights
- Proposed Share Subscription: Eurosports Global Limited has secured approval-in-principle from the Singapore Exchange Securities Trading Limited (SGX-ST) for the proposed issue of 26,500,000 new ordinary shares at S\$0.075 per share. The total value of the proposed subscription is approximately S\$1,987,500.
- SGX-ST Approval Conditions: The SGX-ST’s approval-in-principle is subject to strict compliance with the Catalist Rules, including transparency in the use of proceeds, restrictions on share allocation, and timely placement of shares.
- Placement Timeline: The company must complete the placement of the subscription shares within seven market days from the date of approval (10 June 2026).
- Caution to Shareholders: The completion of the Proposed Subscription remains subject to fulfilment of all conditions precedent in the Subscription Agreement. There is no guarantee of completion.
Details of the Proposed Share Subscription
The board of directors of Eurosports Global Limited announced that the company has received the SGX-ST’s approval-in-principle for the listing and quotation of 26,500,000 new ordinary shares. These shares will be issued at a subscription price of S\$0.075 each, representing a significant fundraising exercise for the company.
The new shares are expected to bring in approximately S\$1.99 million in fresh capital, which may be used to support business growth, fund working capital, or pursue strategic initiatives. Investors should note that the specific breakdown of how the funds will be utilized, particularly for working capital, will be disclosed in future company announcements and in the annual report, as required by SGX Catalist Rules.
SGX-ST Approval Conditions and Compliance
- Use of Proceeds: The company must provide a written undertaking to comply with Rules 704(30) and 1207(20) of the Catalist Rules. This includes detailed disclosures on how the proceeds are used, especially if allocated to working capital.
- Placement Restrictions: The company must confirm that the new shares will not be allotted to persons prohibited under Rule 812(1) of the Catalist Rules (e.g., interested persons or related parties).
- Timeline for Placement: The new shares must be placed out within seven market days from the date of SGX-ST’s approval-in-principle.
- Rule 803 Compliance: The company must undertake to comply with Rule 803 of the Catalist Rules.
The SGX-ST’s approval-in-principle does not represent a judgment on the merits of the company, its business, or its securities.
Potential Price-Sensitive Considerations for Shareholders
- Uncertainty in Completion: The proposed subscription is still subject to various conditions precedent. There is no certainty that the transaction will complete as planned.
- Pace of Execution: The requirement to place out shares within seven market days creates a tight window for completion and introduces some execution risk.
- Impact on Share Capital: If completed, the new shares will dilute existing shareholders but also strengthen the company’s capital base, potentially enabling further growth or financial stability.
Ongoing Disclosure
The company has committed to updating shareholders on all material developments and progress regarding the proposed share subscription through further announcements.
Shareholders and potential investors are advised to exercise caution and consult their professional advisers if in doubt.
Contact and Sponsor Statement
This announcement has been reviewed by the company’s sponsor, RHT Capital Pte. Ltd. For enquiries, the contact person is Mr. Mah How Soon, 36 Robinson Road, #10-06 City House, Singapore 068877, Email: [email protected].
Disclaimer
This article is prepared for informational purposes only and does not constitute investment advice. The Singapore Exchange Securities Trading Limited assumes no responsibility for the content of this article. Investors are advised to exercise caution and seek independent advice where appropriate.
欧励体育全球有限公司获新加坡交易所原则性批准，拟发行2,650万新股融资约199万新元
重点摘要
- 拟议增发股份： 欧励体育全球有限公司获得新交所的原则性批准，拟以每股0.075新元的价格增发26,500,000股普通新股，融资总额约为1,987,500新元。
- 新交所批准条件： 此次批准须严格遵守Catalist板规则，包括对募集资金用途的透明披露、股份分配的限制，以及及时完成股份配售等。
- 配售时限： 公司须在批准之日起七个交易日内完成新股配售。
- 对股东的提醒： 拟议认购完成仍取决于认购协议所有先决条件的实现，能否完成尚无保证。
增发详情
董事会宣布公司已获新交所原则性批准，拟发行26,500,000股新普通股，每股认购价为0.075新元。这将为公司带来约199万新元增量资金，有助于公司业务扩展、补充营运资金或推动战略发展。关于募集资金的具体用途（尤其是营运资金）将在后续公告及年报中详细披露，以符合法规要求。
新交所批准条件与合规要求
- 募集资金用途： 公司须书面承诺遵守Catalist规则704(30)和1207(20)，详细披露募集资金使用情况，特别是用于营运资金的用途。
- 配售限制： 公司须确认不会向Catalist规则812(1)所禁止人士配售新股（如利益相关人或关联方）。
- 配售时限： 新股须在原则性批准之日起七个交易日内完成配售。
- 遵守Rule 803： 公司须承诺遵守Catalist规则803。
新交所的原则性批准不代表对公司、其业务或证券的价值进行判断。
对股东可能造成价格影响的重要事项
- 交易完成的不确定性： 本次认购仍需满足多项先决条件，最终能否完成存在不确定性。
- 执行速度风险： 需在七个交易日内配售新股，存在一定执行风险。
- 股份稀释影响： 若顺利完成，新股的发行将稀释现有股东持股比例，但有助于公司资本实力提升，支持未来发展。
后续披露安排
公司承诺将就本次认购的所有重大进展通过公告及时向股东通报。股东和潜在投资者应谨慎行事，如有疑问请咨询专业顾问。
联系方式及保荐声明
本公告已由公司保荐人RHT Capital Pte. Ltd.审阅。如有疑问，请联系：Mr. Mah How Soon，地址：36 Robinson Road, #10-06 City House, Singapore 068877，邮箱：[email protected]。
免责声明
本文仅供参考，不构成投资建议。新加坡交易所有限公司对本文内容不承担任何责任。投资者应谨慎行事并在适当时寻求独立意见。
